Resultado da Busca
ESMO has Clinical Practice Guidelines on the following Gastrointestinal Cancers: Rectal Cancer, Biliary cancer, Gastric cancer, Oesophageal cancer, Pancreatic cancer, Metastatic colorectal cancer, Anal cancer, Early colon cancer, Familial risk colorectal cancer, Hepatocellular carcinoma.
- Gastrointestinal Cancers: Pancreatic Cancer in The Covid-19 Era
The tiered approach of ESMO in delivering a guidance for...
- Gastrointestinal Cancers: Gastro-oesophageal Tumours in The Covid-19 Era
The tiered approach of ESMO in delivering a guidance for...
- Pan-Asian Adaptation
It was therefore decided, by both the ESMO and the Japanese...
- Metastatic Colorectal Cancer
This ESMO Clinical Practice Guideline provides key...
- Gastric Cancer
ESMO for World Cancer Day 2024; ESMO for World Cancer Day...
- Anal Cancer
Authors: S. Rao, M. G. Guren, K. Khan, G. Brown, A. G....
- Hepatocellular Carcinoma
COVID-19 and cancer care in the ESMO journals; ESMO Brand....
- Guidelines Webinar
Audit the fulfillment of the learning objectives and...
- Gastrointestinal Cancers: Pancreatic Cancer in The Covid-19 Era
25 de out. de 2022 · This ESMO Clinical Practice Guideline provides key recommendations for managing metastatic colorectal cancer. It covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up.
Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023 Jan;34 (1):10-32. doi: 10.1016/j.annonc.2022.10.003. Epub 2022 Oct 25.
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Incidence and epidemiology. The incidence of rectal cancer in the European Union is ∼125 000 per year, i.e. ∼35% of the total colorectal cancer incidence, reflecting 15–25 cases/100 000 population per year and is predicted to increase further in both genders.
- Bengt Glimelius, Lars Påhlman, A. Cervantes
- 2010
25 de out. de 2022 · This European Society for Medical Oncology (ESMO) Guideline describes improvements in diagnosis, staging and treatment of metastatic CRC (mCRC) patients, which have contributed to the current ‘state-of-the-art ’ treat-ment approaches, and provides guidance for the comprehensive management of patients with mCRC.
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016 Aug;27 (8):1386-422. doi: 10.1093/annonc/mdw235. Epub 2016 Jul 5. Authors.
